ALPS ETF Trust - ALPS Medical Breakthroughs ETF (ARCA: SBIO)
Financials · Capital Markets · US
$67.28
-0.49% today · +92.8% 1Y
ALPS ETF Trust - ALPS Medical Breakthroughs ETF (ARCA: SBIO) operates in the Capital Markets industry within the Financials sector. The company is valued at $222.02M.
Over the last twelve months the share price has gained 92.8%, trading between 32.48 and 69.34.
Tweenvest scores ALPS ETF Trust - ALPS Medical Breakthroughs ETF across four factors: dividend 59/100. Its strongest factor is dividend.
SBIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $222.02M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- 2.29%
- Beta (5Y)
- 0.74
- 52-week high
- $69.34
- 52-week low
- $32.48
- Avg volume (3M)
- —
- Shares outstanding
- 3.30M
- Employees
- —
- Next earnings
- —
About ALPS ETF Trust - ALPS Medical Breakthroughs ETF
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
- ISIN
- US00162Q5936
- Founded
- 2014
- Listed since
- Dec 30, 2014
- Exchange
- NYSE Arca
- Currency
- USD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI | $2.31T | $378.15 | +0.29% |
| Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO | $1.67T | $704.02 | +0.31% |
| iShares Trust - iShares Core S&P 500 ETFARCA: IVV | $892.30B | $769.62 | +0.32% |
| State Street SPDR S&P 500 ETF TrustARCA: SPY | $811.28B | $765.91 | +0.32% |
| Invesco QQQ Trust, Series 1NasdaqGM: QQQ | $483.79B | $710.72 | +0.62% |
| Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG | $377.81B | $87.40 | +0.54% |
| Morgan StanleyNYSE: MS | $340.45B | $216.77 | +1.26% |
| The Goldman Sachs Group, Inc.NYSE: GS | $320.59B | $1,058.88 | +2.18% |
Figures last refreshed Aug 18, 2026.